What are the components of Vosevi?

Vosevi is a combination medication used for the treatment of chronic hepatitis C virus (HCV) infection. The correct answer identifies the three components of Vosevi as sofosbuvir, velpatasvir, and voxilaprevir.

Sofosbuvir is a nucleotide analog NS5B polymerase inhibitor, velpatasvir is an NS5A inhibitor, and voxilaprevir is a protease inhibitor. Together, these medications work synergistically to target different stages of the viral life cycle, thereby enhancing the efficacy of the treatment regimen and helping to achieve sustained virologic response in patients with HCV.

Each of the other combinations listed in the options contains different antiviral components that are relevant to other HCV treatments but do not accurately represent the constituents of Vosevi. Understanding the specific components of Vosevi is crucial for healthcare professionals when considering antiviral therapy for hepatitis C, ensuring they can provide targeted and effective care based on the patient's needs.